Cargando…

Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model

Congenital disorders of glycosylation (CDGs) constitute a rapidly growing family of human diseases resulting from heritable mutations in genes driving the production and modification of glycoproteins. The resulting symptomatic hypoglycosylation causes multisystemic defects that include severe neurol...

Descripción completa

Detalles Bibliográficos
Autores principales: Parkinson, William M., Dookwah, Michelle, Dear, Mary Lynn, Gatto, Cheryl L., Aoki, Kazuhiro, Tiemeyer, Michael, Broadie, Kendal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892659/
https://www.ncbi.nlm.nih.gov/pubmed/26940433
http://dx.doi.org/10.1242/dmm.022939
_version_ 1782435433731325952
author Parkinson, William M.
Dookwah, Michelle
Dear, Mary Lynn
Gatto, Cheryl L.
Aoki, Kazuhiro
Tiemeyer, Michael
Broadie, Kendal
author_facet Parkinson, William M.
Dookwah, Michelle
Dear, Mary Lynn
Gatto, Cheryl L.
Aoki, Kazuhiro
Tiemeyer, Michael
Broadie, Kendal
author_sort Parkinson, William M.
collection PubMed
description Congenital disorders of glycosylation (CDGs) constitute a rapidly growing family of human diseases resulting from heritable mutations in genes driving the production and modification of glycoproteins. The resulting symptomatic hypoglycosylation causes multisystemic defects that include severe neurological impairments, revealing a particularly critical requirement for tightly regulated glycosylation in the nervous system. The most common CDG, CDG-Ia (PMM2-CDG), arises from phosphomannomutase type 2 (PMM2) mutations. Here, we report the generation and characterization of the first Drosophila CDG-Ia model. CRISPR-generated pmm2-null Drosophila mutants display severely disrupted glycosylation and early lethality, whereas RNAi-targeted knockdown of neuronal PMM2 results in a strong shift in the abundance of pauci-mannose glycan, progressive incoordination and later lethality, closely paralleling human CDG-Ia symptoms of shortened lifespan, movement impairments and defective neural development. Analyses of the well-characterized Drosophila neuromuscular junction (NMJ) reveal synaptic glycosylation loss accompanied by defects in both structural architecture and functional neurotransmission. NMJ synaptogenesis is driven by intercellular signals that traverse an extracellular synaptomatrix and are co-regulated by glycosylation and matrix metalloproteinases (MMPs). Specifically, trans-synaptic signaling by the Wnt protein Wingless (Wg) depends on the heparan sulfate proteoglycan (HSPG) co-receptor Dally-like protein (Dlp), which is regulated by synaptic MMP activity. Loss of synaptic MMP2, Wg ligand, Dlp co-receptor and downstream trans-synaptic signaling occurs with PMM2 knockdown. Taken together, this Drosophila CDG disease model provides a new avenue for the dissection of cellular and molecular mechanisms underlying neurological impairments and is a means by which to discover and test novel therapeutic treatment strategies.
format Online
Article
Text
id pubmed-4892659
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-48926592016-06-16 Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model Parkinson, William M. Dookwah, Michelle Dear, Mary Lynn Gatto, Cheryl L. Aoki, Kazuhiro Tiemeyer, Michael Broadie, Kendal Dis Model Mech Research Article Congenital disorders of glycosylation (CDGs) constitute a rapidly growing family of human diseases resulting from heritable mutations in genes driving the production and modification of glycoproteins. The resulting symptomatic hypoglycosylation causes multisystemic defects that include severe neurological impairments, revealing a particularly critical requirement for tightly regulated glycosylation in the nervous system. The most common CDG, CDG-Ia (PMM2-CDG), arises from phosphomannomutase type 2 (PMM2) mutations. Here, we report the generation and characterization of the first Drosophila CDG-Ia model. CRISPR-generated pmm2-null Drosophila mutants display severely disrupted glycosylation and early lethality, whereas RNAi-targeted knockdown of neuronal PMM2 results in a strong shift in the abundance of pauci-mannose glycan, progressive incoordination and later lethality, closely paralleling human CDG-Ia symptoms of shortened lifespan, movement impairments and defective neural development. Analyses of the well-characterized Drosophila neuromuscular junction (NMJ) reveal synaptic glycosylation loss accompanied by defects in both structural architecture and functional neurotransmission. NMJ synaptogenesis is driven by intercellular signals that traverse an extracellular synaptomatrix and are co-regulated by glycosylation and matrix metalloproteinases (MMPs). Specifically, trans-synaptic signaling by the Wnt protein Wingless (Wg) depends on the heparan sulfate proteoglycan (HSPG) co-receptor Dally-like protein (Dlp), which is regulated by synaptic MMP activity. Loss of synaptic MMP2, Wg ligand, Dlp co-receptor and downstream trans-synaptic signaling occurs with PMM2 knockdown. Taken together, this Drosophila CDG disease model provides a new avenue for the dissection of cellular and molecular mechanisms underlying neurological impairments and is a means by which to discover and test novel therapeutic treatment strategies. The Company of Biologists Ltd 2016-05-01 /pmc/articles/PMC4892659/ /pubmed/26940433 http://dx.doi.org/10.1242/dmm.022939 Text en © 2016. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Research Article
Parkinson, William M.
Dookwah, Michelle
Dear, Mary Lynn
Gatto, Cheryl L.
Aoki, Kazuhiro
Tiemeyer, Michael
Broadie, Kendal
Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model
title Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model
title_full Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model
title_fullStr Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model
title_full_unstemmed Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model
title_short Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model
title_sort synaptic roles for phosphomannomutase type 2 in a new drosophila congenital disorder of glycosylation disease model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892659/
https://www.ncbi.nlm.nih.gov/pubmed/26940433
http://dx.doi.org/10.1242/dmm.022939
work_keys_str_mv AT parkinsonwilliamm synapticrolesforphosphomannomutasetype2inanewdrosophilacongenitaldisorderofglycosylationdiseasemodel
AT dookwahmichelle synapticrolesforphosphomannomutasetype2inanewdrosophilacongenitaldisorderofglycosylationdiseasemodel
AT dearmarylynn synapticrolesforphosphomannomutasetype2inanewdrosophilacongenitaldisorderofglycosylationdiseasemodel
AT gattocheryll synapticrolesforphosphomannomutasetype2inanewdrosophilacongenitaldisorderofglycosylationdiseasemodel
AT aokikazuhiro synapticrolesforphosphomannomutasetype2inanewdrosophilacongenitaldisorderofglycosylationdiseasemodel
AT tiemeyermichael synapticrolesforphosphomannomutasetype2inanewdrosophilacongenitaldisorderofglycosylationdiseasemodel
AT broadiekendal synapticrolesforphosphomannomutasetype2inanewdrosophilacongenitaldisorderofglycosylationdiseasemodel